Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 10 studies | 27% ± 9% | |
astrocyte | 8 studies | 28% ± 11% | |
epithelial cell | 4 studies | 28% ± 7% | |
oligodendrocyte precursor cell | 4 studies | 26% ± 6% | |
oligodendrocyte | 4 studies | 18% ± 2% | |
B cell | 3 studies | 19% ± 1% | |
endothelial cell | 3 studies | 26% ± 7% | |
GABAergic neuron | 3 studies | 39% ± 8% | |
glutamatergic neuron | 3 studies | 44% ± 13% | |
abnormal cell | 3 studies | 18% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 33% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4297.10 | 1444 / 1445 | 100% | 24.39 | 183 / 183 |
uterus | 100% | 5679.65 | 170 / 170 | 100% | 22.86 | 458 / 459 |
thymus | 100% | 9136.89 | 653 / 653 | 100% | 19.39 | 603 / 605 |
stomach | 100% | 5314.03 | 359 / 359 | 100% | 26.89 | 285 / 286 |
intestine | 100% | 8117.29 | 966 / 966 | 100% | 30.47 | 525 / 527 |
adrenal gland | 100% | 4419.12 | 258 / 258 | 100% | 21.50 | 229 / 230 |
pancreas | 100% | 5497.51 | 328 / 328 | 99% | 28.46 | 177 / 178 |
prostate | 100% | 7139.14 | 245 / 245 | 99% | 22.28 | 499 / 502 |
brain | 99% | 4993.45 | 2617 / 2642 | 100% | 31.93 | 705 / 705 |
bladder | 100% | 4400.19 | 21 / 21 | 99% | 24.43 | 499 / 504 |
ovary | 100% | 5366.27 | 180 / 180 | 99% | 15.40 | 425 / 430 |
kidney | 100% | 6532.43 | 89 / 89 | 99% | 20.84 | 890 / 901 |
liver | 100% | 3500.28 | 226 / 226 | 99% | 14.17 | 401 / 406 |
skin | 100% | 4855.94 | 1809 / 1809 | 99% | 21.01 | 466 / 472 |
breast | 100% | 5935.76 | 459 / 459 | 98% | 18.47 | 1099 / 1118 |
lung | 100% | 4791.02 | 577 / 578 | 98% | 18.64 | 1131 / 1155 |
adipose | 100% | 4478.05 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 16.42 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.12 | 29 / 29 |
spleen | 100% | 8201.15 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.17 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.71 | 1 / 1 |
blood vessel | 100% | 3543.48 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 2943.33 | 789 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 2625.89 | 841 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 2513.77 | 834 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031293 | Biological process | membrane protein intracellular domain proteolysis |
GO_0033619 | Biological process | membrane protein proteolysis |
GO_0010803 | Biological process | regulation of tumor necrosis factor-mediated signaling pathway |
GO_0050776 | Biological process | regulation of immune response |
GO_0006509 | Biological process | membrane protein ectodomain proteolysis |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0098554 | Cellular component | cytoplasmic side of endoplasmic reticulum membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0098553 | Cellular component | lumenal side of endoplasmic reticulum membrane |
GO_0010008 | Cellular component | endosome membrane |
GO_0030660 | Cellular component | Golgi-associated vesicle membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0042500 | Molecular function | aspartic endopeptidase activity, intramembrane cleaving |
GO_0005515 | Molecular function | protein binding |
Gene name | SPPL2B |
Protein name | Signal peptide peptidase like 2B Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) (Intramembrane protease 4) (IMP-4) (Presenilin homologous protein 4) (PSH4) (Presenilin-like protein 1) |
Synonyms | IMP4 PSL1 KIAA1532 |
Description | FUNCTION: Intramembrane-cleaving aspartic protease (I-CLiP) that cleaves type II membrane signal peptides in the hydrophobic plane of the membrane. Functions in ITM2B and TNF processing . Catalyzes the intramembrane cleavage of the anchored fragment of shed TNF-alpha (TNF), which promotes the release of the intracellular domain (ICD) for signaling to the nucleus . May play a role in the regulation of innate and adaptive immunity . Catalyzes the intramembrane cleavage of the simian foamy virus processed leader peptide gp18 of the envelope glycoprotein gp130 dependently of prior ectodomain shedding by furin or furin-like proprotein convertase (PC)-mediated cleavage proteolysis . . |
Accessions | ENST00000618220.4 [Q8TCT7-2] A0A087WZ50 ENST00000613503.5 [Q8TCT7-1] A0A087WWL4 ENST00000614794.4 ENST00000586332.5 ENST00000621568.4 Q8TCT7 A0A087WZ93 ENST00000610743.4 [Q8TCT7-4] ENST00000612623.1 A0A087WT77 |